110 related articles for article (PubMed ID: 34706508)
21. Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.
Zhong Y; Yan J; Deng M; Hu K; Yao Z; Zou Y; Xu R
Exp Biol Med (Maywood); 2013 Aug; 238(8):866-73. PubMed ID: 23828588
[TBL] [Abstract][Full Text] [Related]
22. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
23. Sequencing the full-length of the phosphatase and tensin homolog (PTEN) gene in hepatocellular carcinoma (HCC) using the 454 GS20 and Illumina GA DNA sequencing platforms.
Rodriguez JA; Guiteau JJ; Nazareth L; Reid JG; Goss JA; Gibbs RA; Gingras MC
World J Surg; 2009 Apr; 33(4):647-52. PubMed ID: 19082655
[TBL] [Abstract][Full Text] [Related]
24. Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome.
Hashemi M; Rezaei H; Eskandari-Nasab E; Kaykhaei MA; Taheri M
Mol Med Rep; 2013 Jan; 7(1):342-6. PubMed ID: 23138198
[TBL] [Abstract][Full Text] [Related]
25. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
Wan XW; Jiang M; Cao HF; He YQ; Liu SQ; Qiu XH; Wu MC; Wang HY
J Cancer Res Clin Oncol; 2003 Feb; 129(2):100-6. PubMed ID: 12669234
[TBL] [Abstract][Full Text] [Related]
26. APC promoter methylation and protein expression in hepatocellular carcinoma.
Csepregi A; Röcken C; Hoffmann J; Gu P; Saliger S; Müller O; Schneider-Stock R; Kutzner N; Roessner A; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2008 May; 134(5):579-89. PubMed ID: 17973119
[TBL] [Abstract][Full Text] [Related]
27. Investigation of PTEN promoter methylation in ameloblastoma.
Lapthanasupkul P; Klongnoi B; Mutirangura A; Kitkumthorn N
Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e481-e487. PubMed ID: 32134893
[TBL] [Abstract][Full Text] [Related]
28. Expression of
Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
[TBL] [Abstract][Full Text] [Related]
29. Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma.
Yang Z; Yi J; Li X; Long W
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):45-7. PubMed ID: 15934306
[TBL] [Abstract][Full Text] [Related]
30. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo.
Sun X; Zheng G; Li C; Liu C
Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract][Full Text] [Related]
33. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
34. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
[TBL] [Abstract][Full Text] [Related]
36. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
[TBL] [Abstract][Full Text] [Related]
37. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
38.
Khatami F; Shahriari S; Aminimoghaddam S; Klashami ZN; Farahani MS; Teimoori-Toolabi L; Amoli MM; Asadi M; Rashidi BH
Epigenomics; 2023 Apr; 15(8):507-516. PubMed ID: 37345350
[No Abstract] [Full Text] [Related]
39. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
Li J; Gong P; Lyu X; Yao K; Li X; Peng H
Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
[TBL] [Abstract][Full Text] [Related]
40. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
